{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:05:10Z","timestamp":1778605510477,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00277-024-05846-1","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T02:01:42Z","timestamp":1718762502000},"page":"2729-2741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thrombopoietin receptor agonists regulate myeloid-derived suppressor cell-mediated immunomodulatory effects in ITP"],"prefix":"10.1007","volume":"103","author":[{"given":"Yingqiao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changcheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"issue":"10","key":"5846_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W (2019) Immune Thrombocytopenia. N Engl J Med 381(10):945\u2013955. https:\/\/doi.org\/10.1056\/NEJMcp1810479","journal-title":"N Engl J Med"},{"issue":"1","key":"5846_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/bjh.19079","volume":"203","author":"K Yazdanbakhsh","year":"2023","unstructured":"Yazdanbakhsh K, Provan D, Semple JW (2023) The role of T cells and myeloid-derived suppressor cells in refractory immune thrombocytopenia. Br J Haematol 203(1):54\u201361. https:\/\/doi.org\/10.1111\/bjh.19079","journal-title":"Br J Haematol"},{"issue":"12","key":"5846_CR3","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1182\/blood-2015-10-674531","volume":"127","author":"Y Hou","year":"2016","unstructured":"Hou Y, Feng Q, Xu M, Li GS, Liu XN, Sheng Z et al (2016) High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia. Blood 127(12):1587\u20131597. https:\/\/doi.org\/10.1182\/blood-2015-10-674531","journal-title":"Blood"},{"issue":"2","key":"5846_CR4","doi-asserted-by":"publisher","first-page":"e5637","DOI":"10.1590\/1414-431x20165637","volume":"50","author":"J Zhou","year":"2017","unstructured":"Zhou J, Zhou Y, Wen J, Sun X, Zhang X (2017) Circulating myeloid-derived suppressor cells predict disease activity and treatment response in patients with immune thrombocytopenia. Braz J Med Biol Res 50(2):e5637. https:\/\/doi.org\/10.1590\/1414-431x20165637","journal-title":"Braz J Med Biol Res"},{"issue":"11","key":"5846_CR5","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.imbio.2013.07.003","volume":"218","author":"E Schouppe","year":"2013","unstructured":"Schouppe E, Van Overmeire E, Laoui D, Keirsse J, Van Ginderachter JA (2013) Modulation of CD8(+) T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells. Immunobiology 218(11):1385\u20131391. https:\/\/doi.org\/10.1016\/j.imbio.2013.07.003","journal-title":"Immunobiology"},{"issue":"3","key":"5846_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3):162\u2013174. https:\/\/doi.org\/10.1038\/nri2506","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"5846_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3324\/haematol.2014.115634","volume":"100","author":"M Iraqi","year":"2015","unstructured":"Iraqi M, Perdomo J, Yan F, Choi PY, Chong BH (2015) Immune Thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro. Haematologica 100(5):623\u2013632. https:\/\/doi.org\/10.3324\/haematol.2014.115634","journal-title":"Haematologica"},{"issue":"3","key":"5846_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2015-07-659656","volume":"127","author":"Y Wei","year":"2016","unstructured":"Wei Y, Ji XB, Wang YW, Wang JX, Yang EQ, Wang ZC et al (2016) High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood 127(3):296\u2013302 quiz 370. https:\/\/doi.org\/10.1182\/blood-2015-07-659656","journal-title":"Blood"},{"issue":"7","key":"5846_CR9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41423-022-00859-0","volume":"19","author":"Y Hou","year":"2022","unstructured":"Hou Y, Xie J, Wang S, Li D, Wang L, Wang H et al (2022) Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia. Cell Mol Immunol 19(7):764\u2013776. https:\/\/doi.org\/10.1038\/s41423-022-00859-0","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"5846_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jaad.2016.02.1239","volume":"76","author":"A Caplan","year":"2017","unstructured":"Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG (2017) Prevention and management of glucocorticoid-induced side effects: a comprehensive review: gastrointestinal and endocrinologic side effects. J Am Acad Dermatol 76(1):11\u201316. https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1239","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"5846_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11926-015-0513-4","volume":"17","author":"E Harris","year":"2015","unstructured":"Harris E, Tiganescu A, Tubeuf S, Mackie SL (2015) The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy. Curr Rheumatol Rep 17(6):513. https:\/\/doi.org\/10.1007\/s11926-015-0513-4","journal-title":"Curr Rheumatol Rep"},{"key":"5846_CR12","doi-asserted-by":"publisher","first-page":"109440","DOI":"10.1016\/j.steroids.2024.109440","volume":"207","author":"A Rahman","year":"2024","unstructured":"Rahman A, Haider MF (2024) A comprehensive review on glucocorticoids induced osteoporosis: a medication caused disease. Steroids 207:109440. https:\/\/doi.org\/10.1016\/j.steroids.2024.109440","journal-title":"Steroids"},{"issue":"1","key":"5846_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3138\/cim-2024-2569","volume":"47","author":"J Britto","year":"2024","unstructured":"Britto J, Holbrook A, Sun H, Cserti-Gazdewich C, Prokopchuk-Gauk O, Hsia C et al (2024) Thrombopoietin receptor agonists and other second-line therapies for Immune Thrombocytopenia: a narrative review with a focus on Drug Access in Canada. Clin Invest Med 47(1):13\u201322. https:\/\/doi.org\/10.3138\/cim-2024-2569","journal-title":"Clin Invest Med"},{"issue":"6","key":"5846_CR14","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","volume":"104","author":"W Ghanima","year":"2019","unstructured":"Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB (2019) Thrombopoietin receptor agonists: ten years later. Haematologica 104(6):1112\u20131123. https:\/\/doi.org\/10.3324\/haematol.2018.212845","journal-title":"Haematologica"},{"issue":"12","key":"5846_CR15","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.3390\/jcm12123872","volume":"12","author":"DFH de Barros Torelli","year":"2023","unstructured":"de Barros Torelli DFH, Oliveira CBS, Nai GA, Trindade EM, Prestes-Carneiro LE (2023) Eltrombopag for adults and children with Immune-Refractory Thrombocytopenic Purpura: a systematic review. J Clin Med 12(12):3872. https:\/\/doi.org\/10.3390\/jcm12123872","journal-title":"J Clin Med"},{"issue":"1","key":"5846_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12185-013-1382-0","volume":"98","author":"DJ Kuter","year":"2013","unstructured":"Kuter DJ (2013) The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol 98(1):10\u201323. https:\/\/doi.org\/10.1007\/s12185-013-1382-0","journal-title":"Int J Hematol"},{"issue":"4","key":"5846_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1053\/j.seminhematol.2019.09.001","volume":"56","author":"J Bussel","year":"2019","unstructured":"Bussel J, Kulasekararaj A, Cooper N, Verma A, Steidl U, Semple JW et al (2019) Mechanisms and therapeutic prospects of thrombopoietin receptor agonists. Semin Hematol 56(4):262\u2013278. https:\/\/doi.org\/10.1053\/j.seminhematol.2019.09.001","journal-title":"Semin Hematol"},{"issue":"2","key":"5846_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB et al (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115(2):168\u2013186. https:\/\/doi.org\/10.1182\/blood-2009-06-225565","journal-title":"Blood"},{"issue":"11","key":"5846_CR19","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386\u20132393. https:\/\/doi.org\/10.1182\/blood-2008-07-162503","journal-title":"Blood"},{"issue":"5","key":"5846_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41419-022-04778-w","volume":"13","author":"Y Lei","year":"2022","unstructured":"Lei Y, Huang Y, Lin J, Sun S, Che K, Shen J et al (2022) Mxi1 participates in the progression of lung cancer via the microRNA-300\/KLF9\/GADD34 Axis. Cell Death Dis 13(5):425. https:\/\/doi.org\/10.1038\/s41419-022-04778-w","journal-title":"Cell Death Dis"},{"issue":"2","key":"5846_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/cei.12935","volume":"188","author":"S Audia","year":"2017","unstructured":"Audia S, Santegoets K, Laarhoven AG, Vidarsson G, Facy O, Ortega-Deballon P et al (2017) Fc\u03b3 receptor expression on splenic macrophages in adult immune thrombocytopenia. Clin Exp Immunol 188(2):275\u2013282. https:\/\/doi.org\/10.1111\/cei.12935","journal-title":"Clin Exp Immunol"},{"key":"5846_CR22","doi-asserted-by":"publisher","unstructured":"Ji L, Zhan Y, Cheng Y (2024) New findings and new methods on macrophages in primary immune thrombocytopenia. Br J Haematol. May 3. https:\/\/doi.org\/10.1111\/bjh.19513. Epub ahead of print. PMID: 38699807","DOI":"10.1111\/bjh.19513"},{"issue":"1","key":"5846_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12026-023-09421-0","volume":"72","author":"X Xiong","year":"2024","unstructured":"Xiong X, Zhang Y, Wen Y (2024) Diverse functions of myeloid-derived suppressor cells in autoimmune diseases. Immunol Res 72(1):34\u201349. https:\/\/doi.org\/10.1007\/s12026-023-09421-0","journal-title":"Immunol Res"},{"key":"5846_CR24","doi-asserted-by":"publisher","first-page":"39003","DOI":"10.1038\/srep39003","volume":"6","author":"L Wang","year":"2016","unstructured":"Wang L, Gao Z, Chen XP, Zhang HY, Yang N, Wang FY et al (2016) Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: a systematic review and meta-analysis. Sci Rep 6:39003. https:\/\/doi.org\/10.1038\/srep39003","journal-title":"Sci Rep"},{"issue":"8","key":"5846_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI (2021) Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol 21(8):485\u2013498. https:\/\/doi.org\/10.1038\/s41577-020-00490-y","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5846_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12672-023-00793-1","volume":"14","author":"ZN He","year":"2023","unstructured":"He ZN, Zhang CY, Zhao YW, He SL, Li Y, Shi BL et al (2023) Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer. Discov Oncol 14(1):185. https:\/\/doi.org\/10.1007\/s12672-023-00793-1","journal-title":"Discov Oncol"},{"issue":"12","key":"5846_CR27","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1093\/rheumatology\/keq269","volume":"49","author":"AL Hepburn","year":"2010","unstructured":"Hepburn AL, Narat S, Mason JC (2010) The management of peripheral blood cytopenias in systemic lupus erythematosus. Rheumatology (Oxford) 49(12):2243\u20132254. https:\/\/doi.org\/10.1093\/rheumatology\/keq269","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"5846_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/030097402760375124","volume":"31","author":"SJ Bowman","year":"2002","unstructured":"Bowman SJ (2002) Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol 31(5):251\u2013259. https:\/\/doi.org\/10.1080\/030097402760375124","journal-title":"Scand J Rheumatol"},{"key":"5846_CR29","doi-asserted-by":"publisher","unstructured":"Tomasello R, Giordano G, Romano F, Vaccarino F, Siragusa S, Lucchesi A et al (2021) Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary? Biomedicines 9(9). https:\/\/doi.org\/10.3390\/biomedicines9091170","DOI":"10.3390\/biomedicines9091170"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05846-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05846-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05846-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T17:02:30Z","timestamp":1722099750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05846-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["5846"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05846-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethical committee of Medical Research Ethics Committee of the First Affiliated Hospital of University of Science and Technology of China (2023KY-473) in accordance with the Declaration of Helsinki. All patients gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}